Agenus INC Form 4 insider transactions

Agenus Director Thomas L. Harrison acquired 7,691 shares of common stock at $3.982 per share through a board compensation election policy, increasing his total beneficial ownership to 29,770 shares.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, acquired 4,942 shares of common stock as part of his salary for the pay period ending December 26, 2025.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 4,316 shares of common stock as salary, aligning executive interests with shareholders.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, acquired 3,587 shares of common stock as part of his salary compensation, increasing his direct and indirect beneficial ownership.

Agenus Inc. CEO Garo H. Armen received 3,769 shares of common stock as part of his salary, increasing his direct beneficial ownership.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 4,120 shares of common stock as salary, aligning his interests further with shareholders.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 4,216 shares of common stock as salary, demonstrating alignment with shareholder interests.

Agenus Inc. CEO Garo H. Armen increased his direct beneficial ownership by 3,951 shares of common stock, accepting salary in lieu of cash.

Agenus Inc. Director Timothy Wright acquired 1,704.928 Deferred Stock Units, increasing his beneficial ownership to 21,872.43 units.

Agenus Inc. Director Thomas L. Harrison acquired 5,780 shares of common stock at $5.01 per share as part of his board compensation.

Agenus Inc. CEO Garo H. Armen received 3,734 shares of common stock as salary for the pay period ending September 19, 2025, demonstrating equity-based compensation.

Agenus Inc. CEO Garo H. Armen elected to receive 3,778 shares of common stock valued at $4.33 per share as salary for the pay period ending September 5, 2025.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, elected to receive his salary in common stock, acquiring 3,619 shares at $4.52 per share.

Agenus Inc. CEO Garo H. Armen elected to receive his salary in common stock, signaling confidence in the company's future.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, received 2,745 shares of common stock valued at $5.96 per share as part of his salary for the pay period ending July 25, 2025.

Agenus Inc.'s Chairman and CEO, Garo H. Armen, has elected to receive his salary in common stock, acquiring 2,317 shares at $7.06 per share, effective July 11, 2025.

Agenus Inc. Director Thomas L. Harrison increased his beneficial ownership by acquiring common stock as director fees and receiving stock options under an equity incentive plan.

Agenus Inc. Director Timothy Wright acquired 2,707.834 Deferred Stock Units valued at $3.462 each, increasing his total beneficial ownership to 20,167.502 units.

Agenus Inc. CEO Garo H. Armen has significantly increased his beneficial ownership of company common stock through a 2024 performance bonus award and by electing to receive his salary in shares.

Christine M. Klaskin, Agenus Inc.'s Principal Financial Officer and Principal Accounting Officer, was awarded 15,782 shares of common stock as a 2024 performance bonus.

Agenus Inc.'s Chief Medical Officer, Steven J. O'Day, acquired 43,497 shares of common stock as a 2024 performance bonus, valued at $4.47 per share.

Agenus Inc. director Timothy Wright was granted 15,750 stock options with an exercise price of $3.02 per share, following shareholder approval obtained on June 17, 2025.

Agenus Inc. Director Susan B. Hirsch was granted 15,000 stock options with an exercise price of $3.02, vesting one year from the grant date, following shareholder approval.

Agenus Inc. director Brian Corvese was granted 30,750 stock options with an exercise price of $3.02 per share, effective June 17, 2025, following shareholder approval.

Agenus Inc. disclosed that its Chairman and CEO, Garo H. Armen, was granted 37,500 stock options with an exercise price of $3.02, following shareholder approval on June 17, 2025.

Agenus Inc. officer Christine M. Klaskin was granted 7,250 stock options with a $3.02 exercise price, vesting over three years, following shareholder approval on June 17, 2025.

Agenus Inc. CEO and Director Garo H. Armen has acquired 3,480 shares of common stock as part of his salary payment, increasing his direct and indirect beneficial ownership in the company.

Agenus Inc. Director and Officer Garo H. Armen has increased his direct beneficial ownership by acquiring 4,769 shares of common stock at $3.43 per share, choosing to receive his salary in stock instead of cash.

Agenus Inc. CEO Garo Armen received 4,700 shares of common stock in lieu of cash salary for the pay period ending May 16, 2025, at a price of $3.48 per share.

Director Jennifer Buell acquired 581 shares of Agenus Inc. common stock as part of her salary compensation plan and disposed of 19,738 shares.